EP2882446 - PROPHYLACTIC AND NUTRACEUTICAL THERAPY [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 15.03.2019 Database last updated on 31.08.2024 | |
Former | The patent has been granted Status updated on 06.04.2018 | ||
Former | Grant of patent is intended Status updated on 23.03.2018 | ||
Former | Examination is in progress Status updated on 31.01.2018 | ||
Former | Grant of patent is intended Status updated on 22.10.2017 | ||
Former | Examination is in progress Status updated on 27.01.2017 | Most recent event Tooltip | 10.07.2020 | Lapse of the patent in a contracting state New state(s): IS | published on 12.08.2020 [2020/33] | Applicant(s) | For all designated states HAMLET Pharma AB BMC D10 Klinikgatan 32 222 42 Lund / SE | [2018/10] |
Former [2015/25] | For all designated states HAMLET Pharma AB Lilla Fiskaregatan 10 222 22 Lund / SE | Inventor(s) | 01 /
SVANBORG, Catharina Slottsgatan 32 S-21133 Malmo / SE | 02 /
PUTHIA, Manoj Department of Microbiology Immunology and Glycobiology (MIG) Lund University Solvegatan 23 S-223 62 Lund / SE | 03 /
HO, Chin Shing Department of Microbiology Immunology and Glycobiology (MIG) Lund University Solvegatan 23 S-223 62 Lund / SE | [2015/25] | Representative(s) | Greaves Brewster LLP Copa House Station Road Cheddar, Somerset BS27 3AH / GB | [N/P] |
Former [2015/25] | Greaves, Carol Pauline C P Greaves & Co 80 Church Road Winscombe North Somerset BS25 1BP / GB | Application number, filing date | 13762204.9 | 08.08.2013 | [2018/19] | WO2013GB52132 | Priority number, date | GB20120014234 | 09.08.2012 Original published format: GB 201214234 | GB20120014237 | 09.08.2012 Original published format: GB 201214237 | [2015/25] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2014023976 | Date: | 13.02.2014 | Language: | EN | [2014/07] | Type: | A1 Application with search report | No.: | EP2882446 | Date: | 17.06.2015 | Language: | EN | The application published by WIPO in one of the EPO official languages on 13.02.2014 takes the place of the publication of the European patent application. | [2015/25] | Type: | B1 Patent specification | No.: | EP2882446 | Date: | 09.05.2018 | Language: | EN | [2018/19] | Search report(s) | International search report - published on: | EP | 13.02.2014 | Classification | IPC: | A61K31/201, A61K38/38, A61K35/20, A61K47/12, A23L33/18 | [2017/44] | CPC: |
A61K38/38 (EP,US);
A23L33/18 (EP,US);
A61K31/201 (EP,US);
A61K35/20 (EP,US);
A61K47/12 (EP,US);
A61K9/0095 (EP,US);
A61P35/00 (EP,US)
(-)
| C-Set: |
A61K31/201, A61K2300/00 (EP,US);
A61K35/20, A61K2300/00 (US,EP);
A61K38/38, A61K2300/00 (US,EP)
|
Former IPC [2015/25] | A61K38/01, A61K38/16, A61P35/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/25] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | PROPHYLAKTISCHE UND NUTRAZEUTISCHE THERAPIE | [2015/25] | English: | PROPHYLACTIC AND NUTRACEUTICAL THERAPY | [2015/25] | French: | THÉRAPIE PROPHYLACTIQUE ET NUTRACEUTIQUE | [2015/25] | Entry into regional phase | 06.02.2015 | National basic fee paid | 06.02.2015 | Designation fee(s) paid | 06.02.2015 | Examination fee paid | Examination procedure | 06.02.2015 | Amendment by applicant (claims and/or description) | 06.02.2015 | Examination requested [2015/25] | 26.09.2016 | Despatch of a communication from the examining division (Time limit: M04) | 26.01.2017 | Reply to a communication from the examining division | 22.05.2017 | Despatch of a communication from the examining division (Time limit: M02) | 23.06.2017 | Reply to a communication from the examining division | 23.10.2017 | Communication of intention to grant the patent | 29.01.2018 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 29.01.2018 | Fee for grant paid | 29.01.2018 | Fee for publishing/printing paid | 26.03.2018 | Communication of intention to grant the patent | 04.04.2018 | Receipt of the translation of the claim(s) | Divisional application(s) | EP17187031.4 / EP3295953 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 26.09.2016 | Opposition(s) | 12.02.2019 | No opposition filed within time limit [2019/16] | Fees paid | Renewal fee | 20.08.2015 | Renewal fee patent year 03 | 22.08.2016 | Renewal fee patent year 04 | 22.08.2017 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AL | 09.05.2018 | AT | 09.05.2018 | CY | 09.05.2018 | CZ | 09.05.2018 | EE | 09.05.2018 | HR | 09.05.2018 | LT | 09.05.2018 | LV | 09.05.2018 | MC | 09.05.2018 | MK | 09.05.2018 | PT | 09.05.2018 | RO | 09.05.2018 | RS | 09.05.2018 | SI | 09.05.2018 | SK | 09.05.2018 | SM | 09.05.2018 | TR | 09.05.2018 | LU | 08.08.2018 | MT | 08.08.2018 | BG | 09.08.2018 | GR | 10.08.2018 | BE | 31.08.2018 | IS | 09.09.2018 | [2020/32] |
Former [2020/31] | AL | 09.05.2018 | |
AT | 09.05.2018 | ||
CY | 09.05.2018 | ||
CZ | 09.05.2018 | ||
EE | 09.05.2018 | ||
HR | 09.05.2018 | ||
LT | 09.05.2018 | ||
LV | 09.05.2018 | ||
MC | 09.05.2018 | ||
MK | 09.05.2018 | ||
PT | 09.05.2018 | ||
RO | 09.05.2018 | ||
RS | 09.05.2018 | ||
SI | 09.05.2018 | ||
SK | 09.05.2018 | ||
SM | 09.05.2018 | ||
TR | 09.05.2018 | ||
LU | 08.08.2018 | ||
MT | 08.08.2018 | ||
BG | 09.08.2018 | ||
GR | 10.08.2018 | ||
BE | 31.08.2018 | ||
Former [2020/28] | AL | 09.05.2018 | |
AT | 09.05.2018 | ||
CZ | 09.05.2018 | ||
EE | 09.05.2018 | ||
HR | 09.05.2018 | ||
LT | 09.05.2018 | ||
LV | 09.05.2018 | ||
MC | 09.05.2018 | ||
PT | 09.05.2018 | ||
RO | 09.05.2018 | ||
RS | 09.05.2018 | ||
SI | 09.05.2018 | ||
SK | 09.05.2018 | ||
SM | 09.05.2018 | ||
TR | 09.05.2018 | ||
LU | 08.08.2018 | ||
MT | 08.08.2018 | ||
BG | 09.08.2018 | ||
GR | 10.08.2018 | ||
BE | 31.08.2018 | ||
Former [2020/16] | AL | 09.05.2018 | |
AT | 09.05.2018 | ||
CZ | 09.05.2018 | ||
EE | 09.05.2018 | ||
HR | 09.05.2018 | ||
LT | 09.05.2018 | ||
LV | 09.05.2018 | ||
MC | 09.05.2018 | ||
RO | 09.05.2018 | ||
RS | 09.05.2018 | ||
SI | 09.05.2018 | ||
SK | 09.05.2018 | ||
SM | 09.05.2018 | ||
TR | 09.05.2018 | ||
LU | 08.08.2018 | ||
MT | 08.08.2018 | ||
BG | 09.08.2018 | ||
GR | 10.08.2018 | ||
BE | 31.08.2018 | ||
Former [2020/08] | AL | 09.05.2018 | |
AT | 09.05.2018 | ||
CZ | 09.05.2018 | ||
EE | 09.05.2018 | ||
HR | 09.05.2018 | ||
LT | 09.05.2018 | ||
LV | 09.05.2018 | ||
MC | 09.05.2018 | ||
RO | 09.05.2018 | ||
RS | 09.05.2018 | ||
SI | 09.05.2018 | ||
SK | 09.05.2018 | ||
SM | 09.05.2018 | ||
LU | 08.08.2018 | ||
MT | 08.08.2018 | ||
BG | 09.08.2018 | ||
GR | 10.08.2018 | ||
BE | 31.08.2018 | ||
Former [2019/51] | AL | 09.05.2018 | |
AT | 09.05.2018 | ||
CZ | 09.05.2018 | ||
EE | 09.05.2018 | ||
HR | 09.05.2018 | ||
LT | 09.05.2018 | ||
LV | 09.05.2018 | ||
MC | 09.05.2018 | ||
RO | 09.05.2018 | ||
RS | 09.05.2018 | ||
SI | 09.05.2018 | ||
SK | 09.05.2018 | ||
SM | 09.05.2018 | ||
LU | 08.08.2018 | ||
BG | 09.08.2018 | ||
GR | 10.08.2018 | ||
BE | 31.08.2018 | ||
Former [2019/38] | AT | 09.05.2018 | |
CZ | 09.05.2018 | ||
EE | 09.05.2018 | ||
HR | 09.05.2018 | ||
LT | 09.05.2018 | ||
LV | 09.05.2018 | ||
MC | 09.05.2018 | ||
RO | 09.05.2018 | ||
RS | 09.05.2018 | ||
SI | 09.05.2018 | ||
SK | 09.05.2018 | ||
SM | 09.05.2018 | ||
LU | 08.08.2018 | ||
BG | 09.08.2018 | ||
GR | 10.08.2018 | ||
BE | 31.08.2018 | ||
Former [2019/26] | AT | 09.05.2018 | |
CZ | 09.05.2018 | ||
EE | 09.05.2018 | ||
HR | 09.05.2018 | ||
LT | 09.05.2018 | ||
LV | 09.05.2018 | ||
MC | 09.05.2018 | ||
RO | 09.05.2018 | ||
RS | 09.05.2018 | ||
SI | 09.05.2018 | ||
SK | 09.05.2018 | ||
SM | 09.05.2018 | ||
LU | 08.08.2018 | ||
BG | 09.08.2018 | ||
GR | 10.08.2018 | ||
Former [2019/21] | AT | 09.05.2018 | |
CZ | 09.05.2018 | ||
EE | 09.05.2018 | ||
HR | 09.05.2018 | ||
LT | 09.05.2018 | ||
LV | 09.05.2018 | ||
MC | 09.05.2018 | ||
RO | 09.05.2018 | ||
RS | 09.05.2018 | ||
SK | 09.05.2018 | ||
SM | 09.05.2018 | ||
LU | 08.08.2018 | ||
BG | 09.08.2018 | ||
GR | 10.08.2018 | ||
Former [2019/15] | AT | 09.05.2018 | |
CZ | 09.05.2018 | ||
EE | 09.05.2018 | ||
HR | 09.05.2018 | ||
LT | 09.05.2018 | ||
LV | 09.05.2018 | ||
MC | 09.05.2018 | ||
RO | 09.05.2018 | ||
RS | 09.05.2018 | ||
SK | 09.05.2018 | ||
SM | 09.05.2018 | ||
BG | 09.08.2018 | ||
GR | 10.08.2018 | ||
Former [2019/11] | AT | 09.05.2018 | |
CZ | 09.05.2018 | ||
EE | 09.05.2018 | ||
HR | 09.05.2018 | ||
LT | 09.05.2018 | ||
LV | 09.05.2018 | ||
RO | 09.05.2018 | ||
RS | 09.05.2018 | ||
SK | 09.05.2018 | ||
SM | 09.05.2018 | ||
BG | 09.08.2018 | ||
GR | 10.08.2018 | ||
Former [2019/10] | AT | 09.05.2018 | |
CZ | 09.05.2018 | ||
EE | 09.05.2018 | ||
HR | 09.05.2018 | ||
LT | 09.05.2018 | ||
LV | 09.05.2018 | ||
RO | 09.05.2018 | ||
RS | 09.05.2018 | ||
SK | 09.05.2018 | ||
BG | 09.08.2018 | ||
GR | 10.08.2018 | ||
Former [2019/09] | EE | 09.05.2018 | |
HR | 09.05.2018 | ||
LT | 09.05.2018 | ||
LV | 09.05.2018 | ||
RS | 09.05.2018 | ||
BG | 09.08.2018 | ||
GR | 10.08.2018 | ||
Former [2018/52] | HR | 09.05.2018 | |
LT | 09.05.2018 | ||
LV | 09.05.2018 | ||
RS | 09.05.2018 | ||
BG | 09.08.2018 | ||
GR | 10.08.2018 | ||
Former [2018/51] | HR | 09.05.2018 | |
LT | 09.05.2018 | ||
LV | 09.05.2018 | ||
RS | 09.05.2018 | ||
BG | 09.08.2018 | ||
Former [2018/50] | HR | 09.05.2018 | |
LT | 09.05.2018 | ||
BG | 09.08.2018 | ||
Former [2018/47] | LT | 09.05.2018 | Cited in | International search | [X]WO9926979 (SVANBORG CATHARINA [SE], et al) [X] 1-35 * the whole document *; | [X]WO03074547 (SVANBORG CATHARINA [SE], et al) [X] 1-4,8,10-14 * the whole document *; | [X]WO2005082406 (HAMLET PHARMA AB [SE], et al) [X] 1-4,8,10-14 * the whole document *; | [X]WO2008138348 (NYA HAMLET PHARMA AB [DK], et al) [X] 1-35 * the whole document *; | [X]WO2010131237 (AGRICULTURE AND FOOD DEV AUTHO [IE], et al) [X] 1-35 * the whole document *; | [X] - SVANBORG C ET AL, "HAMLET kills tumor cells by an apoptosis-like mechanism--cellular, molecular, and therapeutic aspects", ADVANCES IN CANCER RESEARCH, ACADEMIC PRESS, US, (20030101), vol. 88, doi:10.1016/S0065-230X(03)88302-1, ISSN 0065-230X, pages 1 - 29, XP002254552 [X] 1-35 * pages 8,18 * DOI: http://dx.doi.org/10.1016/S0065-230X(03)88302-1 | [X] - ANN-KRISTIN MOSSBERG ET AL, "Structure and function of human [alpha]-lactalbumin made lethal to tumor cells (HAMLET)-type complexes", FEBS JOURNAL, (20101101), vol. 277, no. 22, doi:10.1111/j.1742-4658.2010.07890.x, ISSN 1742-464X, pages 4614 - 4625, XP055015362 [X] 1-35 * page 4618 - page 4620 * DOI: http://dx.doi.org/10.1111/j.1742-4658.2010.07890.x | [X] - RAMMER PAUL ET AL, "BAMLET Activates a Lysosomal Cell Death Program in Cancer Cells", MOLECULAR CANCER THERAPEUTICS, AMERICAN ASSOCIATION OF CANCER RESEARCH, US, (20100101), vol. 9, no. 1, doi:10.1158/1535-7163.MCT-09-0559, ISSN 1535-7163, pages 24 - 32, XP009174347 [X] 1-35 * the whole document * DOI: http://dx.doi.org/10.1158/1535-7163.MCT-09-0559 | [XY] - SVENSSON M ET AL, "Conversion of alpha-lactalbumin to a protein inducing apoptosis", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES - PNAS, NATIONAL ACADEMY OF SCIENCES, US, (20000411), vol. 97, no. 8, doi:10.1073/PNAS.97.8.4221, ISSN 0027-8424, pages 4221 - 4226, XP002530615 [X] 1-3,8,10-13 * page 4226 * [Y] 27-33 DOI: http://dx.doi.org/10.1073/pnas.97.8.4221 | [XY] - KNYAZEVA E L ET AL, "Who is Mr. HAMLET? Interaction of human [alpha]-lactalbumin with monomeric oleic acid", BIOCHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, (20081209), vol. 47, no. 49, ISSN 0006-2960, pages 13127 - 13137, XP009174339 [X] 1-3,8,10-13 * page 13129, column l * * page 13135, column r, paragraph l - page 13136, column l, paragraph 1 * [Y] 27-33 DOI: http://dx.doi.org/10.1021/bi801423s | Examination | - MOSSBERG A K ET AL, "HAMLET Treatment Delays Bladder Cancer Development", JOURNAL OF UROLOGY, LIPPINCOTT WILLIAMS & WILKINS, BALTIMORE, MD, US, vol. 183, no. 4, ISSN 0022-5347, (20100401), pages 1590 - 1597, (20100315), XP026967349 |